Slingshot Bio's Intellectual Property
As of 5/29/26
Copyright
Unless otherwise indicated, the content on this website, including text, graphics, images, product information, design elements, software, code, and other materials, is owned by, licensed to, or used with permission by Slingshot Biosciences, Inc. and is protected by U.S. and international copyright laws. No content may be copied, reproduced, distributed, displayed, transmitted, modified, or otherwise used without Slingshot’s prior written permission, except as permitted by law.
Trademarks
SLINGSHOT®, FLOWCYTES®, SPECTRACOMP®, VIACOMP®, TRUCYTES®, SCATTERBRIDGE®, SCATTERGRID®, and SB® are registered trademarks of Slingshot Biosciences, Inc. in the United States and/or other jurisdictions.
NANOCYTES™, QUANTCYTES™, STIMCYTES™, PHENOCYTES™, SLINGSHOTBIO™, CELL MIMIC™, PRECISION ENGINEERED CELL MIMIC™, TBNK MIMIC™, CD34+ STEM CELL MIMIC™, T CELL MEMORY MIMIC™, T CELL EXHAUSTION/ACTIVATION MIMIC™, FLUOROCYTES™, VIACYTES™, the SLINGSHOT BIOSCIENCES name and logo, and other Slingshot names, product names, service names, logos, slogans, and trade dress are trademarks or applied-for trademarks of Slingshot Biosciences, Inc. in the United States and/or other jurisdictions.
Patent Marking
The following Slingshot Biosciences products and product families may be protected by one or more patents in the United States and other jurisdictions. This page is intended to provide notice under 35 U.S.C. § 287(a) and other applicable virtual patent marking provisions.
Products listed below may be sold individually or as components of kits, panels, custom products, or combination products. Additional patents and patent applications may be pending in the United States and internationally. This list may not be all-inclusive, and the association between Slingshot products and patents may change due to patent issuance, publication, expiration, abandonment, licensing, product changes, or other circumstances. The absence of any product, patent, patent application, or jurisdiction from this page does not waive or limit any legal rights of Slingshot Biosciences, Inc.
Product / Product Family
Patent Coverage
Instrument Standardization & Harmonization Including FlowCytes®, ScatterBridge®, and related instrument setup, scatter, calibration, linearity, and performance-monitoring controls.
FlowCytes® and related synthetic cell mimic controls may be covered by one or more of U.S. Patent Nos. 9,714,897; 9,915,598; 10,753,846; 10,942,109; 11,313,782; 11,726,023; 11,747,261; 11,761,877; 11,927,519; 12,038,369; 12,066,369; 12,228,492; and 12,352,679. ScatterBridge®, ScatterGrid®, and related scatter standardization technologies may be covered by pending U.S. and international patent applications.
Spectral Unmixing & Compensation Including SpectraComp®, ViaComp®, ViaComp® Flex, and related compensation, spectral unmixing, autofluorescence, viability, and panel setup controls.
May be covered by one or more of U.S. Patent Nos. 9,714,897; 9,915,598; 10,481,068; 10,753,846; 10,942,109; 11,313,782; 11,726,023; 11,747,261; 11,761,877; 11,927,519; 12,038,369; 12,066,369; 12,130,285; 12,228,492; 12,332,241; and 12,352,679. Additional U.S. and international patents and applications may apply.
Immunophenotyping Controls Including PhenoCytes™, TBNK Mimic™, CD34+ Stem Cell Mimic™, TruCytes® custom biomarker controls, and related gating, immune-monitoring, biomarker, and synthetic cell mimic controls.
May be covered by one or more of U.S. Patent Nos. 9,714,897; 9,915,598; 10,753,846; 10,942,109; 11,747,261; 11,761,877; 11,927,519; 12,066,369; 12,352,679; and 12,461,007. Additional U.S. and international patents and applications may apply.
Quantitative Antigen Density Including QuantCytes™ and related antigen-density, expression-benchmarking, antibody-binding, and quantitative biomarker controls.
May be covered by one or more of U.S. Patent Nos. 9,714,897; 9,915,598; 10,753,846; 10,942,109; 11,747,261; 11,927,519; 12,066,369; 12,352,679; and 12,461,007. Additional U.S. and international patents and applications may apply.
Functional CAR-T Benchmarking Including StimCytes™ and related CAR-T potency, immune activation, cytokine-release, antigen-presenting, feeder-cell, and cell-therapy benchmarking controls.
May be covered by one or more of U.S. Patent Nos. 12,134,779; 12,196,661; 12,312,595; and 12,352,679. Additional U.S. and international patents and applications may apply.
Additional Patent Information
Slingshot Biosciences also owns or controls additional patents and patent applications relating to synthetic cell mimic technologies, optical barcoding, multiplexing, red blood cell mimic and hematology reference compositions, apoptotic cell mimic controls, magnetic capture, feeder-cell and antigen-presenting cell technologies, surface-charge modified cell mimics, nucleic-acid-based live/dead assay technologies, osmolarity controls, and related hydrogel or polymer particle technologies.
Additional U.S. patents include U.S. Patent Nos. 11,598,768; 11,686,661; 12,276,659; and 12,379,387. Additional U.S. and international patents and applications may apply.
Foreign patents and counterparts may include patents or patent applications in Australia, Canada, China, Europe, Hong Kong, India, Japan, South Korea, Taiwan, and other jurisdictions.
No License
Nothing on this page grants or should be construed as granting any license or right under any patent, trademark, copyright, trade secret, or other intellectual property right of Slingshot Biosciences, Inc. or any third party, whether by implication, estoppel, or otherwise.